Drug
Zw49
Zw49: highest development phase Phase 1, developed by Zymeworks. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zymeworks
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZW49 NCT03821233 | Phase 1 | HER2-expressing Cancers |
Latest
No recent events.
Follow Zw49 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.